Stefano Rusconi
0000-0002-0375-9990
98 papers found
Refreshing results…
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial
Epidemiology of Mycobacterium avium infection in northern Italy [9]
Cutaneous infection caused by Mycobacterium gordonae in a human immunodeficiency virus-infected patient receiving antimycobacterial treatment [6]
In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate [9]
In vitro antibody production (IVAP) in the follow-up of pédiatrie human immunodeficiency virus type 1-infected patients
No Evidence of a Higher Risk of Progression to AIDS in Patients with HIV-1-Related Severe Thrombocytopenia:
Chemokine production in HIV-seropositive long-term asymptomatic individuals [2]
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people
AIDS in a long-term HIV-1-infected patient with a stable high CD4+ cell count and conserved CD4+CD45RO+subpopulation [2]
Human immunodeficiency virus (HIV) phenotype and interleukin- 2/interleukin-10 ratio are associated markers of protection and progression in HIV infection
Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.
In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.
Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection
Still's disease in a patient infected with human immunodeficiency virus type I
Tracheoesophageal fistula in an HIV-1-positive man due to dual infection of Candida albicans and cytomegalovirus
Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitro.
Mycobacterial infections in AIDS: An overview of epidemiology, clinical manifestations, therapy and prophylaxis
Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases
Missing publications? Search for publications with a matching author name.